Sep 30, 2023Preliminary Results from INTEGRIS-PSC Phase 2a Clinical TrialExciting news about the Pliant Therapeutics PSC clinical trial preliminary results from their global INTEGRIS-PSC Phase 2a trial for...
Jun 24, 2023PRIMIS (Phase 3 Study of Cilofexor) News from EASL Congress 2023News from the EASLCongress 2023 meeting in Vienna From the "late-breaking" abstract session on June 24, 2023, results of the pre-planned...
Sep 28, 2022PRIMIS (Phase 3 Study of Cilofexor) NewsStatement From Gilead Sciences on September 27, 2022 Early Termination of Gilead-Sponsored Study GS-US-428-4194: A Phase 3, Randomized,...
Mar 1, 2021Proof of Concept Phase 2 Trial of IMU-838 with Early Positive ResultsA proof-of-concept Phase 2 trial conducted by Mayo Clinic and sponsored by Immunic has shown very early positive results. We hope that...